Raymond James Financial Inc. Makes New Investment in Inari Medical, Inc. (NASDAQ:NARI)

Raymond James Financial Inc. purchased a new stake in shares of Inari Medical, Inc. (NASDAQ:NARI) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 19,599 shares of the company’s stock, valued at approximately $1,001,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Invesco Ltd. boosted its stake in Inari Medical by 0.6% during the 4th quarter. Invesco Ltd. now owns 129,758 shares of the company’s stock valued at $6,624,000 after purchasing an additional 771 shares during the last quarter. Bank of Montreal Can boosted its position in shares of Inari Medical by 7.8% during the fourth quarter. Bank of Montreal Can now owns 6,212 shares of the company’s stock valued at $317,000 after buying an additional 450 shares during the last quarter. Quadrant Capital Group LLC increased its holdings in Inari Medical by 12.3% in the 4th quarter. Quadrant Capital Group LLC now owns 1,301 shares of the company’s stock worth $66,000 after buying an additional 143 shares in the last quarter. Wells Fargo & Company MN raised its position in Inari Medical by 2.6% in the 4th quarter. Wells Fargo & Company MN now owns 105,742 shares of the company’s stock worth $5,398,000 after buying an additional 2,678 shares during the last quarter. Finally, Motley Fool Asset Management LLC lifted its stake in Inari Medical by 10.4% during the 4th quarter. Motley Fool Asset Management LLC now owns 62,872 shares of the company’s stock valued at $3,210,000 after acquiring an additional 5,913 shares during the period. Institutional investors own 90.98% of the company’s stock.

Inari Medical Stock Performance

NASDAQ NARI opened at $79.97 on Monday. Inari Medical, Inc. has a 12 month low of $39.76 and a 12 month high of $79.99. The stock has a market cap of $4.68 billion, a price-to-earnings ratio of -59.24 and a beta of 1.02. The company’s 50 day moving average is $79.97 and its two-hundred day moving average is $68.43.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on NARI shares. Baird R W cut shares of Inari Medical from a “strong-buy” rating to a “hold” rating in a report on Tuesday, January 7th. BTIG Research reiterated a “neutral” rating on shares of Inari Medical in a research note on Wednesday, January 8th. Canaccord Genuity Group restated a “hold” rating and issued a $80.00 price target (up from $74.00) on shares of Inari Medical in a research note on Tuesday, January 7th. Robert W. Baird reissued a “neutral” rating and issued a $80.00 target price (down previously from $81.00) on shares of Inari Medical in a report on Tuesday, January 7th. Finally, Piper Sandler boosted their price target on Inari Medical from $52.00 to $80.00 and gave the company a “neutral” rating in a research note on Tuesday, January 7th. Twelve research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $69.22.

About Inari Medical

Inari Medical, Inc builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation.